Aprogen Biologics Inc. Logo

Aprogen Biologics Inc.

Develops and manufactures novel biologic drugs and biosimilars for the professional market.

003060 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 송파구 백제고분로 480 4층 (방이동, 풍문빌딩), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Aprogen Biologics Inc. is a biopharmaceutical company specializing in the research, development, and manufacturing of advanced biologic medicines. Founded in 2000, the company leverages proprietary technologies in antibody and recombinant protein engineering to create a pipeline of both novel drugs and biosimilars. Its portfolio is focused on developing biosimilar products for various major biologics, including infliximab, trastuzumab, and rituximab, alongside a range of novel drug candidates. The company aims to provide innovative and accessible medicines for the professional medication market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.6 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 5.0 MB
2025-08-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 102.1 KB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 639.1 KB
2025-05-26 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 67.8 KB
2025-05-26 00:00
M&A Activity
타법인주식및출자증권취득결정
Korean 17.7 KB
2025-05-22 00:00
Related Party Transaction
타법인주식및출자증권처분결정
Korean 16.0 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 3.2 MB
2025-05-07 00:00
Related Party Transaction
[기재정정]임원ㆍ주요주주특정증권등거래계획보고서
Korean 73.8 KB
2025-05-07 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 103.2 KB
2025-05-07 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-04-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 94.2 KB
2025-04-25 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-04-25 00:00
Capital/Financing Update
주권관련사채권의처분결정
Korean 16.4 KB
2025-04-11 00:00
Capital/Financing Update
타인에대한담보제공결정
Korean 15.7 KB

Automate Your Workflow. Get a real-time feed of all Aprogen Biologics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Aprogen Biologics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.